Amdocs (NASDAQ:DOX – Get Free Report)‘s stock had its “peer perform” rating restated by stock analysts at Wolfe Research in a report released on Thursday,Benzinga reports.
DOX has been the topic of a number of other research reports. Stifel Nicolaus cut their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Bank of America reduced their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $101.67.
View Our Latest Research Report on Amdocs
Amdocs Stock Performance
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period last year, the firm earned $1.70 earnings per share. The firm’s revenue was down 9.0% on a year-over-year basis. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. As a group, equities research analysts predict that Amdocs will post 6.21 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of DOX. Harbor Capital Advisors Inc. bought a new stake in Amdocs during the 3rd quarter valued at $26,000. Root Financial Partners LLC bought a new position in shares of Amdocs in the third quarter worth $26,000. Quarry LP grew its position in shares of Amdocs by 42.2% in the first quarter. Quarry LP now owns 391 shares of the technology company’s stock valued at $36,000 after purchasing an additional 116 shares in the last quarter. Atlantic Union Bankshares Corp bought a new stake in shares of Amdocs during the 3rd quarter valued at $37,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in Amdocs during the 1st quarter worth about $39,000. 92.02% of the stock is owned by institutional investors.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
- Five stocks we like better than Amdocs
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
- Using the MarketBeat Dividend Tax Calculator
- As Warren Buffett Nears His Exit, Berkshire’s Amassed Record Cash
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rare Earth Stocks: The Truce That Isn’t a Truce
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
